Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: Results of a randomized, controlled comparison

To determine if newer influenza vaccines can safely improve seroprotection rates of older adults, we compared three licensed trivalent inactivated vaccines (TIVs) in a randomized, controlled trial with evaluator blinding. Participants were non-frail adults ≥ 65 y old, annually TIV-immunized. Study v...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Scheifele, David W., McNeil, Shelly A., Ward, Brian J., Dionne, Marc, Cooper, Curtis, Coleman, Brenda, Loeb, Mark, Rubinstein, Ethan, McElhaney, Janet, Hatchette, Todd, Li, Yan, Montomoli, Emanuele, Schneeberg, Amy, Bettinger, Julie A., Halperin, Scott A., Research Network, PHAC/CIHR Influenza
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Landes Bioscience 2013
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3981857/
https://ncbi.nlm.nih.gov/pubmed/23839537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.25580
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller